Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study

Iben F Sorgenfrei, Kathrine Norrild, Per Bo Larsen, Jakob Stensballe, Doris Ostergaard, Martine E Prins, Jørgen Viby-Mogensen

    256 Citationer (Scopus)

    Abstract

    Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced block.
    OriginalsprogEngelsk
    TidsskriftAnesthesiology
    Vol/bind104
    Udgave nummer4
    Sider (fra-til)667-74
    Antal sider8
    ISSN0003-3022
    StatusUdgivet - 1 apr. 2006

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study'. Sammen danner de et unikt fingeraftryk.

    Citationsformater